Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-06

Clinical Trial Update: Efficacy of Gabapentin in Alcohol Dependency Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial update on gabapentin for alcohol dependence completed, reporting efficacy in reducing alcohol consumption.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: Chulalongkorn University | Conditions: Alcohol Drinking, Heavy Drinking | Phase 3 | Status: COMPLETED